Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic Diabetes insipidus

American Journal of the Medical Sciences

Volumn 316, Issue 5, 1998, Pages 300-309

  Deen, Peter M T ^a   Knoers, Nine V A M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Aquaporin; Mutation; Nephrogenic diabetes insipidus; Routing; Signal transduction

Indexed keywords

AQUAPORIN; DESMOPRESSIN; VASOPRESSIN; VASOPRESSIN V2 RECEPTOR;

CONFERENCE PAPER; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; KIDNEY DISEASE; NEPHROGENIC DIABETES INSIPIDUS; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; WATER RETENTION; WATER TRANSPORT;

EID: 0031728110     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199811000-00003     Document Type: Conference Paper

References (78)

1. Nielsen S, Agre P. The aquaporin family of water channels in kidney. Kidney Int. 1995;48:1057-68.
2. Maeda Y, Smith BL, Agre P, Knepper MA. Quantification of Aquaporin-CHIP water channel protein in microdissected renal tubules by fluorescence-based ELISA. J Clin Invest. 1995;95:422-8.
3. Preston GM, Smith BL, Zeidel ML, Moulds JJ, Agre P. Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels. Science. 1994;265: 1585-7.
4. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature. 1993;361: 549-52.
5. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knepper MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A. 1995;92:1013-7.
6. Knepper MA, Wade JB, Terris J, Ecelbarger CA, Marples D, Mandon B, et al. Renal aquaporins. Kidney Int. 1996;49:1712-7.
7. Wade JB, Stetson DL, Lewis SA. ADH action: evidence for a membrane shuttle mechanism. Ann N Y Acad Sci. 1981; 372:106-17.
8. Marples D, Knepper MA, Christensen EI, Nielsen S. Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol. 1995;38:C655-64.
9. Katsura T, Ausiello DA, Brown D. Direct demonstration of aquaporin-2 water channel recycling in stably transfected LLC-PK1 epithelial cells. Am J Physiol. 1996;39:F548-53.
10. Deen PMT, Rijss JPL, Mulders SM, Errington RJ, van Baal J, van Os CH. Aquaporin-2 transfection of MDCK cells reconstitutes vasopressin-regulated transcellular osmotic water transport. J Am Soc Nephrol. 1997;8:1493-501.
11. Frigeri A, Gropper MA, Turck CW, Verkman AS. Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci U S A. 1995;92:4328-31.
12. Ma T, Chou C-L, Yang MA, Knepper MA, Verkman AS. Decreased urinary ability and inner medullary collecting duct water permeability in transgenic mice lacking aquaporin-4 [abstract]. J Am Soc Nephrol. 1997;8:21A.
13. Martin PY, Schrier RW. Pathogenesis of water and sodium retention in cirrhosis. Kidney Int. 1997;59:S43-9.
14. Martin PY, Schrier RW. Sodium and water retention in heart failure: pathogenesis and treatment. Kidney Int. 1997;59:S57-61.
15. Schrier RW, Howard RL. Unifying hypothesis of sodium and water regulation in health and disease. Hypertension. 1991;18(suppl5):III164-8.
16. Nielsen S, Terris J, Andersen D, Ecelbarger C, Frokiaer J, Jonassen T, et al. Congestive heart failure in rats is associated with increased expression and targeting of aquaporin-2 water channel in collecting duct. Proc Natl Acad Sci U S A. 1997;94:5450-5.
17. Xu DL, Martin PY, Ohara M, St John J, Pattison T, Meng XZ, et al. Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J Clin Invest. 1997;99:1500-5.
18. Asahina Y, Izumi N, Enomoto N, Sasaki S, Fushimi K, Marumo F, et al. Increased gene expression of water channel in cirrhotic rat kidneys. Hepatology. 1995;21:169-73.
19. Fujita N, Ishikawa S, Sasaki S, Fujisawa G, Fushimi K, Marumo F, et al. Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats. Am J Physiol. 1995;38:F926-31.
20. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest. 1995;95:1838-45.
21. Marples D, Frokiaer J, Dorup J, Knepper MA, Nielsen S. Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest. 1996;97:1960-8.
22. Frokiaer J, Marples D, Knepper MA, Nielsen S. Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP-2 water channel in rat kidney. Am J Physiol. 1996;39:F657-68.
23. Apostol E, Ecelbarger CA, Terris J, Bradford AD, Andrews P, Knepper MA. Reduced renal medullary water channel expression in puromycin aminonucleoside-induced nephrotic syndrome. J Am Soc Nephrol. 1997;8:15-24.
24. Sands JM, Naruse M, Jacobs JD, Wilcox JN, Klein JD. Changes in aquaporin-2 protein contribute to the urine concentrating defect in rats fed a low-protein diet. J Clin Invest. 1996;97:2807-14.
25. Bichet DG, Hendy GN, Lonergan M, Arthus MF, Ligier S, Pausova Z, et al. X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies. Am J Hum Genet. 1992;51(5):1089-102.
26. Knoers N, Monnens LA. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment. Pediatr Nephrol. 1992;6(5):476-82.
27. Langley JM, Balfe JW, Selander T, Ray PN, Clarke JT. Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. Am J Med Genet. 1991;38(1):90-4.
28. Bichet DG, Arthus M-F, Lonergan M, Balfe W, Skorechi K, Nivet H, et al. Autosomal dominant and autosomal recessive nephrogenic diabetes insipidus: novel mutations in the AQP2 gene [abstract]. J Am Soc Nephrol. 1995;6:717.
29. Knoers N, Monnens LA. A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney. Eur J Pediatr. 1991;150:370-3.
30. Moses AM, Miller JL, Levine MA. Two distinct pathophysiological mechanisms in congenital nephrogenic diabetes insipidus. J Clin Endocrinol Metab. 1988;66:1259-64.
31. Ohzeki T, Igarashi T, Okamoto A. Familial cases of congenital nephrogenic diabetes insipidus type II: remarkable increment of urinary adenosine 3′ 5′-monophosphate in response to antidiuretic hormone. J Pediatr. 1984;104:593-5.
32. Knoers N, van der Heyden H, van Oost BA, Monnens L, Willems J, Ropers HH. Three-point linkage analysis using multiple DNA polymorphic markers in families with X-linked nephrogenic diabetes insipidus. Genomics. 1989;4(3):434-7.
33. Lolait SJ, O'Carroll AM, McBride OW, Konig M, Morel A, Brownstein MJ. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature. 1992;357:336-9.
34. Pan Y, Metzenberg A, Das S, Jing B, Gitschier J. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus. Nat Genet. 1992;2(2):103-6.
35. Van den Ouweland AM, Dreesen JC, Verdijk M, Knoers NV. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet. 1992;2:99-102.
36. Rosenthal W, Seibold A, Antaramian A, Lonergan M, Arthus MF, Hendy GN, et al. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature. 1992;359:233-5.
37. Deen PMT, Weghuis DO, Sinke RJ, Geurts van Kessel A, Wieringa B, van Os CH. Assignment of the human gene for the water channel of renal collecting duct aquaporin 2 (AQP2) to chromosome 12 region q12-q13. Cytogenet Cell Genet. 1994;66:260-2.
38. Deen PMT, Verdijk MA, Knoers NV, Wieringa B, Monnens LA, van Os CH, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science. 1994;264:92-5.
39. Van Lieburg AF, Verdijk MA, Knoers W, van Essen AJ, Proesmans W, Mallmann R, et al. Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet. 1994;55:648-52.
40. Walz T, Typke D, Smith BL, Agre P, Engel A. Projection map of aquaporin-1 determined by electron crystallography. Nat Struct Biol. 1995;2:730-2.
41. Van Lieburg AF, Knoers W, Mallmann R, Proesmans W, van den Heuvel LP, Monnens LA. Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene. Nephron. 1996;72(4):544-6.
42. Hochberg Z, van Lieburg A, Even L, Brenner B, Lanir N, van Oost BA, et al. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. J Clin Endocrinol Metab. 1997;82:686-9.
43. Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, et al. Hemodynamic and coagulation responses to 1-desamino [8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med. 1988;318(14):881-7.
44. Van Lieburg AF, Knoers NVAM, Monnens LAH, Smits P. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V-2 receptor defect. J Hypertension. 1995;13:1695-700.
45. Knoers N, Brommer EJ, Willems H, van Oost BA, Monnens LA. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus [see comments]. Nephron. 1990;54(4):322-6.
46. Hashemi S, Palmer DS, Aye MT, Ganz PR. Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells. J Cell Physiol. 1993;154(3):496-505.
47. Van Lieburg AF, Verdijk MA, Schoute F, Ligtenberg MJ, van Oost BA, Waldhauser F, et al. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet. 1995;96:70-8.
48. Knoers NVAM. Molecular characterization of nephrogenic diabetes insipidus. Trends Endocrinol Metab. 1994;5:422-8.
49. Fujiwara TM, Morgan K, Bichet DG. Molecular biology of diabetes insipidus. Annu Rev Med. 1995;46:331-43.
50. Bichet DG. Vasopressin receptors in health and disease. Kidney Int. 1996;49(6):1706-11.
51. Bichet DG, Birnbaumer M, Lonergan M, Arthus MF, Rosenthal W. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic. Am J Hum Genet. 1994;55:278-86.
52. Cheong HI, Park HW, Ha IS, Moon HN, Choi Y, Ko KW, et al. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus. Nephron. 1997;75:431-7.
53. Wenkert D, Schoneberg T, Merendino JJ, Pena MSR, Vinitsky R, Goldsmith PK, et al. Functional characterization of five V2 vasopressin receptor gene mutations. Mol Cell Endocrinol. 1996;124:43-50.
54. Pan Y, Wilson P, Gitschier J. The effect of eight V2 vasopressin receptor mutations on stimulation. J Biol Chem. 1994;269:31933-7.
55. Pelham HR. Control of protein exit from the endoplasmic reticulum. Annu Rev Cell Biol. 1989;5(s):1-23.
56. Hammond C, Helenius A Quality control in the secretory pathway. Curr Opin Cell Biol. 1995;7:523-9.
57. Tsukaguchi H, Matsubara H, Taketani S, Mori Y, Seido T, Inada M. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J Clin Invest. 1995;96:2043-50.
58. Sadeghi HM, Innamorati G, Birnbaumer M. An X-linked NDI mutation reveals a requirement for cell surface V2R expression. Mol Endocrinol. 1997;11:706-13.
59. Oksche A, Schulein R, Rutz C, Liebenhoff U, Dickson J, Muller H, et al. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Mol Pharmacol. 1996; 50:820-8.
60. Faux MC, Scott JD. More on target with protein phosphorylation: conferring specificity by location. Trends Biochem Sci. 1996;21:312-5.
61. Yokoyama K, Yamauchi A, Izurni M, Itoh T, Ando A, Imai E, et al. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol. 1996;7:410-4.
62. Rosenthal W, Antaramian A, Gilbert S, Birnbaumer M. Nephrogenic diabetes insipidus: a V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem. 1993; 268:13030-3.
63. Birnbaumer M, Gilbert S, Rosenthal W. An extracellular congenital nephrogenic diabetes insipidus mutation. Mol Endocrinol. 1994;8:886-94.
64. Van Lieburg AF, Verdijk MA, Knoers NVAM, Afer E, Pastina R, Fahrenholz F, et al. In vitro expression of mutations in the V2 receptor gene: confirmation of their role in the pathogenesis of X-linked nephrogenic diabetes insipidus [abstract]. Pediatr Nephrol. 1994;8:c75.
65. Jung JS, Preston GM, Smith BL, Guggino WB, Agre P. Molecular structure of the water channel through aquaporin CHIP: the hourglass model. J Biol Chem. 1994;269:14648-54.
66. Canfield M, Tamarappoo BK, Moses AM, Verkman AS, Holtzman EJ. Novel AQP2 mutations as a cause of partially dDAVP-responsive post V2 receptor congenital nephrogenic diabetes insipidus (CNDI) [abstract]. J Am Soc Nephrol. 1996;7:1611.
67. Mulders SM, Knoers NVAM, Vanlieburg AF, Monnens LAH, Leumann E, Wuhl E, et al. New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol. 1997;8:242-8.
68. Oksche A, Moller A, Dickson J, Rosendahl W, Rascher W, Bichet DG, et al. Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus. Hum Genet. 1996;98:587-9.
69. Deen PMT, Croes H, van Aubel RA, Ginsel LA, van Os CH. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest. 1995;95:2291-6.
70. Schmitz A, Maintz M, Kehle T, Herzog V. In vivo iodination of a misfolded proinsulin reveals co-localized signals for Bip binding and for degradation in the ER. EMBO J. 1995;14(6):1091-8.
71. Smith BL, Agre P. Erythrocyte Mr 28,000 transmembrane protein exists as a multisubunit oligomer similar to channel proteins. J Biol Chem. 1991;266:6407-15.
72. Verbavatz JM, Brown D, Sabolic I, Valenti G, Ausiello DA, van Hoek AN, et al. Tetrameric assembly of CHIP28 water channels in liposomes and cell membranes: a freeze-fracture study. J Cell Biol. 1993;123:605-18.
73. Van Hoek AN, Hom ML, Luthjens LH, de Jong MD, Dempster JA, van Os CH. Functional unit of 30 kDa for proximal tubule water channels as revealed by radiation inactivation. J Biol Chem. 1991;266:16633-5.
74. Copeland CS, Zimmer KP, Wagner KR, Healey GA, Mellman I, Helenius A. Folding, trimerization, and transport are sequential events in the biogenesis of influenza virus hemagglutinin. Cell. 1988;53:197-209.
75. De Silva A, Braakman I, Helenius A. Posttranslational folding of vesicular stomatitis virus G protein in the ER: involvement of noncovalent and covalent complexes. J Cell Biol. 1993;120:647-55.
76. Musil LS, Goodenough DA. Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell. 1993;74:1065-77.
77. Van Lieburg AF. Congenital nephrogenic diabetes insipidus: molecular pathogenesis and clinical aspects. Thesis, University of Nijmegen, Nijmegen, The Netherlands, 1996.
78. Yuasa H, Ito M, Oiso Y, Kurokawa M, Watanabe T, Oda Y, et al. Novel mutations in the V2 vasopressin receptor gene in two pedigrees. J Clin Endocrinol Metab. 1994;79:361-5.